psoriatic-arthritis

Documents about psoriatic-arthritis

• Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE)#907473ClinicalTrials.gov
• Prevalence and predictors of kinesiophobia in psoriatic arthritis: the role of central sensitization and comorbidities#395168Gestión del Repositorio Documental de la Universidad de Salamanca
• COVID-19 VaccinE Response in Rheumatology Patients#148583ClinicalTrials.gov
• Do Nanobubbles Improve Joint Hypoxia?#811454ClinicalTrials.gov
• A Randomized, Double-blind Clinical Trial on the Efficacy of a Dietary Formulation Containing Medium-chain Triglycerides (MCT) and Fiber in Patients With Psoriatic Arthritis#849596ClinicalTrials.gov
• A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis#863251ClinicalTrials.gov
• Carpal Tunnel Syndrome in Patients With Psoriatic Arthritis; Ultrasonography and Magnetic Resonance Imaging Findings#881872ClinicalTrials.gov
• A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis#910751ClinicalTrials.gov
• Abatacept Bone Effects in Psoriatic Arthritis With Bone Biomarker#833417ClinicalTrials.gov
• Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical Practice#836112ClinicalTrials.gov
• Small Changes Behavioural Weight Loss Treatment Approach for Psoriatic Arthritis Patients With Comorbid Obesity#825186ClinicalTrials.gov
• Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.#873333ClinicalTrials.gov
• Response to Upadacitinib of Enthesitis Evaluated by Ultrasound in Patients With Psoriatic Arthritis#873585ClinicalTrials.gov
• Evaluation of the Role of Inflammatory and Structural Ultrasound Abnormalities by Explaining the Perspective of Patients With Psoriatic Arthritis#979150ClinicalTrials.gov
• Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment#405225ClinicalTrials.gov
• TNFAIP3 Gene Expression in Ankylosing Spondylitis and Psoriatic Arthritis Patients and Its Relation to Disease Activity#833293ClinicalTrials.gov
• A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis#865277ClinicalTrials.gov
• A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.#889050ClinicalTrials.gov
• Centocor Microarray Study of Patients#916521ClinicalTrials.gov
• Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.#829305ClinicalTrials.gov
• A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis#871679ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis#881615ClinicalTrials.gov
• A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)#881734ClinicalTrials.gov
• Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis#902711ClinicalTrials.gov
• Web-based Support to Manage Arthritis Pain#892715ClinicalTrials.gov
• Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.#1010611ClinicalTrials.gov
• Obstructive sleep apnea in psoriatic arthritis: clinical characteristics and comorbidities#395167Gestión del Repositorio Documental de la Universidad de Salamanca
• Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy#807496ClinicalTrials.gov
• A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis#915523ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy#877869ClinicalTrials.gov
• A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197#898423ClinicalTrials.gov
• Tracking Biologics Along the Silk Road#839934ClinicalTrials.gov
• The NOR-SWITCH Study#847677ClinicalTrials.gov
• Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)#840355ClinicalTrials.gov
• Influence of Biological Sex on Participant Characteristics, Guselkumab Efficacy and Radiographic Progression in Active Psoriatic Arthritis: Post Hoc Analysis of Three Randomized Trials#253975HAL (France)
• Employment and Arthritis: Making it Work#839147ClinicalTrials.gov
• Follow-up of Person-centered Care of Young Adults With Rheumatic Disease#859456ClinicalTrials.gov
• Korean Post-marketing Surveillance for Xeljanz XR#979928ClinicalTrials.gov
• Evaluation of TWEAK in Plaque Psoriasis and Psoriatic Arthritis Patients#888942ClinicalTrials.gov
• A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)#802404ClinicalTrials.gov
• SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE#912629ClinicalTrials.gov
• A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis#854625ClinicalTrials.gov
• Computational Identification of Repurposable Drug Candidates for Psoriatic Arthritis via Single-Cell RNA Sequencing of Synovial Tissue#174079Zenodo (CERN)
• State of art and future challenges to early intervention, and management in patients with psoriasis at increased risk of transition to psoriatic arthritis: a review#392077IRIS
• Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine#807614ClinicalTrials.gov
• Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium#836263ClinicalTrials.gov
• A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia#812066ClinicalTrials.gov
• Impact of Air Pollution on the Course of Inflammatory Rheumatism#831211ClinicalTrials.gov
• Mindfulness Based Stress Reduction in Rheumatic Diseases#837194ClinicalTrials.gov
• Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis#897027ClinicalTrials.gov